Cargando…
Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes
PURPOSE OF REVIEW: To discuss the current understanding of “β cell identity” and factors underlying altered identity of pancreatic β cells in diabetes, especially in humans. RECENT FINDINGS: Altered identity of β cells due to dedifferentiation and/or transdifferentiation has been proposed as a mecha...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689286/ https://www.ncbi.nlm.nih.gov/pubmed/31401713 http://dx.doi.org/10.1007/s11892-019-1194-6 |
_version_ | 1783443014966837248 |
---|---|
author | Moin, Abu Saleh Md Butler, Alexandra E. |
author_facet | Moin, Abu Saleh Md Butler, Alexandra E. |
author_sort | Moin, Abu Saleh Md |
collection | PubMed |
description | PURPOSE OF REVIEW: To discuss the current understanding of “β cell identity” and factors underlying altered identity of pancreatic β cells in diabetes, especially in humans. RECENT FINDINGS: Altered identity of β cells due to dedifferentiation and/or transdifferentiation has been proposed as a mechanism of loss of β cells in diabetes. In dedifferentiation, β cells do not undergo apoptosis; rather, they lose their identity and function. Dedifferentiation is well characterized by the decrease in expression of key β cell markers such as genes encoding major transcription factors, e.g., MafA, NeuroD1, Nkx6.1, and Foxo1, and an increase in atypical or “disallowed” genes for β cells such as lactate dehydrogenase, monocarboxylate transporter MCT1, or progenitor cell genes (Neurog3, Pax4, or Sox9). Moreover, altered identity of mature β cells in diabetes also involves transdifferentiation of β cells into other islet hormone producing cells. For example, overexpression of α cell specific transcription factor Arx or ablation of Pdx1 resulted in an increase of α cell numbers and a decrease in β cell numbers in rodents. The frequency of α-β double-positive cells was also prominent in human subjects with T2D. These altered identities of β cells likely serve as a compensatory response to enhance function/expand cell numbers and may also camouflage/protect cells from ongoing stress. However, it is equally likely that this may be a reflection of new cell formation as a frank regenerative response to ongoing tissue injury. Physiologically, all these responses are complementary. SUMMARY: In diabetes, (1) endocrine identity recapitulates the less mature/less-differentiated fetal/neonatal cell type, possibly representing an adaptive mechanism; (2) residual β cells may be altered in their subtype proportions or other molecular features; (3) in humans, “altered identity” is a preferable term to dedifferentiation as their cellular fate (differentiated cells losing identity or progenitors becoming more differentiated) is unclear as yet. |
format | Online Article Text |
id | pubmed-6689286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-66892862019-08-23 Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes Moin, Abu Saleh Md Butler, Alexandra E. Curr Diab Rep Pathogenesis of Type 1 Diabetes (A Pugliese and SJ Richardson, Section Editors) PURPOSE OF REVIEW: To discuss the current understanding of “β cell identity” and factors underlying altered identity of pancreatic β cells in diabetes, especially in humans. RECENT FINDINGS: Altered identity of β cells due to dedifferentiation and/or transdifferentiation has been proposed as a mechanism of loss of β cells in diabetes. In dedifferentiation, β cells do not undergo apoptosis; rather, they lose their identity and function. Dedifferentiation is well characterized by the decrease in expression of key β cell markers such as genes encoding major transcription factors, e.g., MafA, NeuroD1, Nkx6.1, and Foxo1, and an increase in atypical or “disallowed” genes for β cells such as lactate dehydrogenase, monocarboxylate transporter MCT1, or progenitor cell genes (Neurog3, Pax4, or Sox9). Moreover, altered identity of mature β cells in diabetes also involves transdifferentiation of β cells into other islet hormone producing cells. For example, overexpression of α cell specific transcription factor Arx or ablation of Pdx1 resulted in an increase of α cell numbers and a decrease in β cell numbers in rodents. The frequency of α-β double-positive cells was also prominent in human subjects with T2D. These altered identities of β cells likely serve as a compensatory response to enhance function/expand cell numbers and may also camouflage/protect cells from ongoing stress. However, it is equally likely that this may be a reflection of new cell formation as a frank regenerative response to ongoing tissue injury. Physiologically, all these responses are complementary. SUMMARY: In diabetes, (1) endocrine identity recapitulates the less mature/less-differentiated fetal/neonatal cell type, possibly representing an adaptive mechanism; (2) residual β cells may be altered in their subtype proportions or other molecular features; (3) in humans, “altered identity” is a preferable term to dedifferentiation as their cellular fate (differentiated cells losing identity or progenitors becoming more differentiated) is unclear as yet. Springer US 2019-08-10 2019 /pmc/articles/PMC6689286/ /pubmed/31401713 http://dx.doi.org/10.1007/s11892-019-1194-6 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Pathogenesis of Type 1 Diabetes (A Pugliese and SJ Richardson, Section Editors) Moin, Abu Saleh Md Butler, Alexandra E. Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes |
title | Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes |
title_full | Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes |
title_fullStr | Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes |
title_full_unstemmed | Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes |
title_short | Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes |
title_sort | alterations in beta cell identity in type 1 and type 2 diabetes |
topic | Pathogenesis of Type 1 Diabetes (A Pugliese and SJ Richardson, Section Editors) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689286/ https://www.ncbi.nlm.nih.gov/pubmed/31401713 http://dx.doi.org/10.1007/s11892-019-1194-6 |
work_keys_str_mv | AT moinabusalehmd alterationsinbetacellidentityintype1andtype2diabetes AT butleralexandrae alterationsinbetacellidentityintype1andtype2diabetes |